The abuse deterrent formulation (ADF) platform technology

Safe, tailored and innovative controlled release formulations to protect your product and patient.

  • Deters various routes of abuse, including injection and solvent extraction.
  • Versatile platform – can be tailored for multiple administration routes – oral, sublingual and parenteral.
  • Tested and proven across a range of compounds of varying solubility levels, including Opioids.
  • In-vitro bioequivalence of the tablet formulation to RLD (Reference Listed Drug).
  • Advanced controlled release – a range of release profiles and triggers.
  • Intelligent design, developed with the patient in mind – flexible dosage form (powder/tablets/suspensions).

Contact us


(US) +1-919-504-4900

(UK) +44 (0)1782 764389